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ABSTRACT
Nucleic acid mimics of fluorescent proteins can
be valuable tools to locate and image functional
biomolecules in cells. Stacking between the inter-
nal G-quartet, formed in the mimics, and the ex-
ogenous fluorophore probes constitutes the basis
for fluorescence emission. The precision of recog-
nition depends upon probes selectively targeting
the specific G-quadruplex in the mimics. However,
the design of probes recognizing a G-quadruplex
with high selectivity in vitro and in vivo remains a
challenge. Through structure-based screening and
optimization, we identified a light-up fluorescent
probe, 9CI that selectively recognizes c-MYC Pu22 G-
quadruplex both in vitro and ex vivo. Upon binding,
the biocompatible probe emits both blue and green
fluorescence with the excitation at 405 nm. With 9CI
and c-MYC Pu22 G-quadruplex complex as the fluo-
rescent response core, a DNA mimic of fluorescent
proteins was constructed, which succeeded in locat-
ing a functional aptamer on the cellular periphery.
The recognition mechanism analysis suggested the
high selectivity and strong fluorescence response
was attributed to the entire recognition process con-
sisting of the kinetic match, dynamic interaction, and
the final stacking. This study implies both the single
stacking state and the dynamic recognition process
are crucial for designing fluorescent probes or lig-
ands with high selectivity for a specific G-quadruplex
structure.
INTRODUCTION
G-quadruplex structures have been demonstrated to play
important roles in mediating biological processes including
functioning as diagnostic tools (1–7). However, the lack of
ligands or fluorescent probes selectively targeting a specific
G-quadruplex topology limits their unambiguous identifi-
cation in live cells (8–10). Endogenic 4-hydroxybenzlidene
imidazolinone (HBI) formed from three residues in the
nascent green fluorescent proteins (GFP), work as essen-
tial visualizing tools that locates proteins and monitors bio-
logical process in living cells and organisms (11–13). As in-
trinsically fluorescent RNA is not known, anRNA aptamer
‘Spinach’ was identified as mimics of GFPwithHBI deriva-
tives as the exogenous fluorophores (14–16). Crystal struc-
tures demonstrated that it was the two-layer non-canonical
G-quadruplex and an adjacent base-triplet in the RNA ap-
tamer that served as a pocket to accommodate HBI deriva-
tives, and restrain their vibration (17,18). Similar restraint
was assumed to occur in DNA mimics of red fluorescent
proteins and other RNA fluogenic light-up aptamers, such
as Mango and Corn (19,20). The stacking between the G-
quartet surface and the fluorophores constitutes the basis
for the fluorescent property of these RNA\DNA mimics
of FPs, which provide tools for genetic encoding of fluo-
rescent nucleic acids and for tracking bio-molecules in cells
(17,18,21,22). However, precision of these nucleic acidmim-
ics of FPs on locating target biological molecules in cells is
affected by multiple G-quadruplexes that can form physio-
logically (23,24). They share a common G-quartet surface,
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which has a potential to interact with the exogenous analogs
of HBI (25–30). To improve precision, it is essential to de-
velopmethods for designing probes that recognize a specific
G-quadruplex forming oligonucleotide with high selectivity
and specificity in vitro and in vivo (9,10,31–34).
G-quadruplexes (G4) are four-stranded structures
formed by guanine-rich DNA or RNA sequences, in
which four guanines are assembled in a square co-planar
arrangement by Hoogsteen hydrogen bonding to form a
G-quartet (26–30). The G-quartets stack on top of one
another to form a G-quadruplex. G-quadruplex-forming
sequences are widely distributed in eukaryotic telomeres
(35,36), and the promoter regions of genes such as c-MYC
(37–39), c-KIT (40,41), k-RAS (42,43), BCL2 (44,45) and
VEGF (46,47). G-quadruplex structures can be classified
into various groups according to the orientation of the
nucleic acid strands, such as parallel, antiparallel or hybrids
thereof, and these structures share a common G-quartet.
In the reported G-quadruplex–ligand complex structures
in PDB, most of ligands interact with G-quadruplex via
G-quartet stacking (30,48). Some compounds display
light-up fluorescence property when interacting with
G-quadruplex, and part of them exhibit selectivity to
distinguish G-quadruplexes from the DNA duplex struc-
ture, which is derived from the - stacking between the
planar aromatic core of the compounds and the common
G-quartet surface (49,50). However, generic G-quartet
stacking results in poor selectivity between G-quadruplex
structures. Interaction with the flanking loops around the
G-quartet enhances the binding of the stacked ligands
(51). The adjacent grooves extend the binding pockets,
and dynamic movement between G-quadruplex and the
ligands explore more intermediate states (52,53). These
could provide more diversified space for designing ligands
with selectivity for a specific G-quadruplex structure.
The design of probes that recognizes a G-quadruplex
topology with high selectivity and specificity in vitro and
in vivo remains a challenge. In this study, we approach
this issue by identifying a fluorescent probe that selectively
recognizes c-MYC Pu22 G-quadruplex structure with the
sequence (5′-TGAGGGTGGGTAGGGTGGGTAA-3′). c-
MYC oncogene is overexpressed in some genetic aberrant
solid tumors (54,55). The G-rich strand in its promoter
region was assumed to mediate transcription through the
formation of G-quadruplex structures. c-MYC Pu22 G-
quadruplex forming sequence is modified from the wild-
type sequence with two base mutations from G to T
(Supplementary Table S1). This G-quadruplex adopts a
propeller-type parallel conformation with 3′ and 5′ flank-
ing sequences stacking on the top and the bottom end of
the G-quadruplex structure, respectively (PDB code 1xav,
Figure 2) (52). The complex structure between this G-
quadruplex and quindoline (PDB code 2l7v) confirmed
the stability of the G-quartet core and explored possi-
ble binding pockets for ligands or probes recognizing c-
MYC Pu22 G-quadruplex (53). Generally, light-up fluo-
rescent probes for biomolecules consist of a recognition
group and a fluorescent signaling unit linked via rotat-
able bonds (32,56–58). The intra-molecular vibration of
the fluorescent probes in their free state disperses their
energy at the excited state. Stacking with biomolecules
Scheme 1. Structure of 6-(2-(anthracen-9-ylmethylene) hydrazinyl)-
N2,N4-diphenyl-1,3,5-triazine-2,4-diamine (9CI) and its division into sub-
structures. The triazine ring is labeled asA, andB represents the anthracene
ring. C and D represent the phenyl rings. Nitrogen atoms connecting the
triazine ring and the phenyl rings are labeled as 1 and 2, respectively.
immobilizes the coplanar chromophore and ensures the
dominance of fluorescence emission in excited state en-
ergy release (56). In this study, virtual screening based
on the pockets was carried out to identify fluorescent
probes of c-MYC Pu22 G-quadruplex. Commercially avail-
able compounds with fluorophores were docked into the
ligand binding cavities in the structures to judge their
fitness, and in vitro fluorescence assay was employed to
measure their fluorescent response. Using identified hits
as templates for further optimization, compound 9CI (6-
(2-(anthracen-9-ylmethylene) hydrazinyl)-N2,N4-diphenyl-
1,3,5-triazine-2,4-diamine; Scheme 1) was identified to se-
lectively recognize c-MYC Pu22 G-quadruplex over other
G-quadruplex structures in in vitro assays and ex vivo ex-
periments. A DNA mimic of fluorescent proteins with this
oligonucleotide and 9CI as the fluorescent response core
located functional aptamer SL1 on the periphery of A549
human lung carcinoma cells. The interacting mode and the
binding process analysis between 9CI and c-MYC Pu22 G-
quadruplex highlighted that the entire recognition process
might consist of a kinetic match, dynamic interaction, and
the final stacking. This recognition mechanism rational-
izes the high selectivity of 9CI, and has been further sup-
ported by the relationship between the structures of anal-




All oligonucleotides used in this study were purchased
from Sangon (Shanghai, China). G-quadruplex forming
oligonucleotides were annealed in the buffer (10 mM
K2HPO4/KH2PO4 pH 7.0, 100 mM KCl) by heating to
95◦C for 5 min, followed by gradual cooling to room tem-
perature. Most compounds in this study were purchased
from the Chinese national compound library of Peking
University (PKU-CNCL), and compounds 5 (9Cl) and 6
were synthesized in-house (Scheme S1). During the synthe-
sis, all chemical reagents were commercially available and
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noted. Silica gel column chromatography (CC) (silica gel
200–300 mesh) was ordered from Qingdao Makall Group
Co., Ltd, Qingdao, China. 1H NMR and 13C NMR spectra
were recorded in DMSO-d6 on a 600MHz Varian VNMRS
Spectrometer and resonances were given in ppm relative to
tetramethylsilane (TMS). The following abbreviations were
used to designate chemical shift multiplicities: s = singlet, d
= doublet, t = triplet, m = multiplet, br = broad. High-
resolution mass spectra (HRMS) were acquired in posi-
tive mode on a MALDI SYNAPT G2 high-definition mass
spectrometer (Waters, Milford, MA, USA).
Synthesis of 9Cl (compound 5) and compound 6
Compounds I (1.0 equivalent) and compound II (1.0 equiv-
alent) (Scheme S1) were synthesized according to the liter-
ature (59,60). Both of them were dissolved in 10 ml anhy-
drous EtOH, and two drops of acetic acid were added to the
mixture. The reaction was kept at 80◦C for 7 h; and then,
the solvent was removed under reduced pressure, and the
residue was purified by silica column chromatography to get
9Cl (compound 5) and 6 as yellow solid.
For compound 5 (9Cl): 73% yields. 1H NMR (600 MHz,
DMSO-d6): 11.22 (s, 1H), 9.44 (s, 3H), 8.80 (s, 1H), 8.70 (d,
J= 6.0Hz, 2H), 8.17 (d, J= 6.0Hz, 2H), 7.95–7.90 (m, 4H),
7.65–7.59 (m, 4H), 7.28 (s, 4H), 7.00 (s, 2H). 13C NMR (150
MHz, DMSO-d6): 164.87, 164.71, 142.27, 140.60, 131.46,
129.96, 129.41, 128.85, 127.42, 125.98, 125.57, 122.38,
120.60, 120.52. HRMS cacld for [M+H]+: 482.2088, found:
482.2104.
For compound 6: 80% yields. 1H NMR (600 MHz,
DMSO-d6): 11.17 (s, 1H), 9.47 (s, 2H), 8.62 (s, 1H), 8.58
(s, 1H), 8.45 (s, 1H), 8.18–8.10 (m, 6H), 7.90 (s, 3H),
7.56–7.54 (m, 2H), 7.34 (s, 4H), 7.03 (t, J = 7.2 Hz, 2H).
13C NMR (150 MHz, DMSO-d6): 164.77, 164.33, 143.34,
140.60, 133.00, 132.17, 132.15, 131.73, 131.54, 129.15,
128.95, 128.84, 128.62, 128.60, 127.16, 126.66, 126.47,
122.46, 122.41, 120.68. HRMS cacld for [M+H]+: 482.2088,
found: 482.2149.
Fluorescence measurement
Fluorescence spectra were scanned by Spectrofluoropho-
tometer RF-5301PC (Shimadzu, Japan) at room tempera-
ture. For fluorescence intensity measurement, 0.5 M an-
nealed DNA samples were mixed with compounds at 0.5
M in the buffer (10 mM K2HPO4/KH2PO4 pH 7.0,
100 mMKCl), and the mixture was incubated for 10 min at
30◦Cbefore the spectra collection. Full UV absorbance pro-
files were scanned for compounds and mixture with DNA
and compounds. The peaks appeared in the profile were
used as the initial excitation wavelengths to obtain the emis-
sion spectra, in which, the maximum emission wavelength
was determined. With the fixed maximum emission wave-
lengths, the peak wavelength in the excitation spectra was
chosen as the final excitation wavelengths. For the fluo-
rescence change of 9CI with the titration of DNA sam-
ples, small aliquots of annealed DNA oligonucleotide were
added into the solution with 0.5 M 9Cl in the buffer (10
mM K2HPO4/KH2PO4 pH 7.0, 100 mM KCl). The final
concentration of DNA samples varied from 0 to 2 M.
The mixture with DNA and 9CI was stirred and allowed
to equilibrate for 10 min at 30◦C before the measurement.
The emission between 420 and 580 nm was recorded at the
excitation wavelength of 405 nm with 5 nm excitation slit
width and 5 nm emission slit width.
The fluorescence variation of 9CI with the titra-
tion of c-MYC Pu 22 G-quadruplex was used to de-
rive Ka value according to the method of Benesi–
Hildebrand (61), using the following equation: 1/(F) =
1/(b[DNA][H]0Ka)+1/(b[H]0). F represents the change in
the fluorescence intensity (F = F –F0); F denotes the flu-
orescence intensity in the presence of different concentra-
tion of c-MYC DNA; F0 is the maximum fluorescence in-
tensity of the free compound 9Cl. [DNA] is the total added
c-MYC Pu 22 G-quadruplex forming oligonucleotide con-
centration, and [H]0 is the total concentration of compound
9Cl.
Gel electrophoresis
The native gel electrophoresis was performed on a 20%
polyacrylamide gel in 1× TBE running buffer containing
100 mM KCl at room temperature. 8 l annealed DNA
(10 M) in 1× loading buffer were loaded into the differ-
ent wells except for c-MYC Pu22 (20 M) in lane 3. The
electrophoresis ran at 100 V. SYBR Gold was used to stain
one gel, after being diluted ten thousand times with TBE
(Tris–borate–EDTA) buffer. The second gel was obtained
with DNA samples premixed with 20 M 9CI before the
electrophoresis. Bands were detected by Tanon-1600 trans-
UV light. The UV wavelength used for image acquisition is
302 nm.
Cell cytotoxicity assay
The cell growth effect of 9CI against A549 (human lung car-
cinoma cell) were tested viameasuring the quantity of living
cells using the Cell Counting Kit-8 (CCK8) (DOJINDO,
Japan) according to the instruction. A549 cells were cul-
tured in Dulbecco’s Modified Eagle Medium (Gibco) with
1% glutamine and 10% fetal bovine serum (FBS) for 24 h
at 37◦C. These cells were treated with 9CI at the indicated
concentrations (2.5, 5, 10, 20 M) for 24 h. Then, 100 l
of 10% CCK-8 solution was added into wells, and the cells
were incubated for another 1 h at 37◦C.The cytotoxicitywas
evaluated basing on the percentage of cell survival in a dose-
dependent manner regard to the control, and the optical
density (OD) detected at 450 nm by automated microplate
reader (Bio-Rad) was used to calculate the survival rate. All
the experiments were performed in parallel and in triplicate.
Confocal imaging of co-localization
A549 cells were cultured in Dulbecco’s modified Eagle’s
medium (Gibco) with 1% glutamine and 10% fetal bovine
serum (FBS) for 24 h at 37◦C. 40 pmol annealed c-MYC
Pu22, TTA and c-KIT1 G-quadruplex forming oligonu-
cleotides labelled with 5′-Cy5 was transfected into cells by
using lipofectamine 2000 (Thermo Fisher) and incubated
at 37◦C for 5 h. Then 5 M 9CI was added and incubated
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Table 1. Sequences of the oligonucleotides used in imaging SL1
Name Sequence(5’-3’) 
Cy5-c-MYC Pu22 5’-Cy5-TGAGGGTGGGTAGGGTGGGTAA 
Cy5-TTA 5’-Cy5-GGGTTAGGGTTAGGGTTAGGG 







a confocal laser scanning microscopy (Olympus FV1000-
MP). The location of 9CI in the cells was investigated by
the fluorescence signal collected between 425–470 nm/500–
545 nm at ex = 405 nm, and the location of G-quadruplex
was checked by fluorescence signal collected between 655
and 755 nm with the excitation at 635 nm.
Bio-imaging for the functional aptamers in live cells
A549 cells was incubatedwith SL1-M (Table 1) for 30min at
room temperature, and washed by 1 ml DPBS twice. Then,
the cells were incubated with 500 nMMFPs (c-MYC Pu22-
MFP/ TTA-MFP, Table 1) and 5 M9CI for 10 min. Fluo-
rescence was collected at 425–470 and 500–545 nm emission
channels after the cells were washed with DPBS three times
again.
Isothermal titration calorimetry
This experiment was carried out with MicroCal iTC200
(Malvern Instruments, Great Britain) at 25◦C. 400 l 9CI
(20 M in 10 mM K2HPO4/KH2PO4 buffer with 0.2%
DMSO, pH 7.0) was loaded into the sample cell and 100
l c-MYC Pu22 G-quadruplex oligonucleotide at 150 M
in the same buffer was prepared for titration. For a typical
titration, 2 l of DNA solution was injected into the sam-
ple cell with 9CI at 150 s interval with a stirring speed of
1000 rpm. Each injection lasted for 5 s, and 20 injections
constituted the whole titration process. The heat output per
injection was obtained through integration, and corrected
by subtracting the dilution heat, which was determined by
injecting the DNA solution into the buffer under the iden-
tical experimental conditions. The Kb value was obtained
through fitting the binding isotherms by Origin.
Circular dichroism
CD spectra were collected with MOS-500 spectrophotome-
ter (bio-logic, France) at room temperature by using a
quartz cuvette with a 1 mm path length. 10 M DNA
oligonucleotides and 20M9CI dissolved in buffer (10mM
K2HPO4/KH2PO4, 100 mMKCl, pH 7.0) were used in the
assay. The spectrum signals between 230 and 320 nm were
scanned with 1 nm bandwidth at 1 nm/s.
Job plots
The stoichiometry between c-MYC Pu22 G-quadruplex
and 9CI was assessed by independent experiments at vari-
ous concentrations ofG-quadruplex and 9CI, while the sum
of their concentrations was kept constant at 2 M. Samples
containing the suitable amount of 9CI were mixed with the
correspondent amount of annealed G-quadruplex, and the
fluorescence signal was measured after 10 min incubation.
The fluorescence intensities of the solutions at the emission
wavelength 472 nmwere plotted as the function of the input
mole fractions of 9CI. The break point in the resulting plot
corresponded to the mole fraction of 9CI in the complex.
Automated docking
Virtual screening for fluorescent probes was carried out by
the combined usage of AutoDock Vina (62) and Autodock
4.0 (63). Compounds with fluorophores from the database
PKU-CNCL were clustered according to Tanimoto sim-
ilarity analysis (64), and the representative compounds
with similarity coefficient smaller than 0.7 were chosen
as the candidates for virtual screening. Three-dimensional
coordinates of c-MYC Pu22 DNA G-quadruplex (PDB
codes: 1xav and 2l7v) (52,53) were retrieved from PDB
(www.rscb.org). The ligand in the structure was removed,
and two potassium ions were placed in the central elec-
tronegative channel. The final coordinate was converted
into the PDBQT format using the graphical user inter-
face AutoDock Tools (ADT) (http://autodock.scripps.edu/
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Figure 1. Structures of compounds 1–9 and their fluorescence response to eighteen DNA oligonucleotides. The excitation and emission wavelengths of
these compounds are listed in Supplementary Table S2.
charges were assigned to the selected representative com-
pounds. A search box centered at the quality center of com-
pound quindoline in the complex structure was set up with
size x = 30, size y = 25, size z = 23 to encompass the
cleft and three grooves in the c-MYC Pu22 G-quadruplex
structure. Ten separate docking runs were performed for
each selected compound by AutoDock Vina, using the de-
fault search parameters. Compounds with docking scores
from AutoDock Vina in the top 30% were re-docked using
Autodock 4.0 for more accurate docking. Grid points of 80
× 66 × 60 with a 0.375 A˚ spacing, centered on quindoline
structure were calculated for all the ligand atom types using
AutoGrid 4.2. Each docking calculation with Autodock 4.0
consisted of 25 million energy evaluations and a maximum
of 270 000 generations using the Lamarckian genetic algo-
rithm local searchmethod.A population size of 300 and 300
rounds of Solis and Wets local search were applied with a
probability of 0.06. A mutation rate of 0.02 and a crossover
rate of 0.8 were used to generate new docking trials for sub-
sequent generations, and the best individual from each gen-
eration was propagated to the next generation. One hun-
dred binding poses were predicted for each compound by
Autodock 4.0, and were clustered with root-mean-square
deviation (RMSD) cutoff value 2 A˚. The predicted binding
poses with the frequency of occurrence higher than 10/100
were visually inspected for their fitness with the binding
pocket.
Molecular dynamics simulations
The stability of 9CI interacting with c-MYC Pu22 G-
quadruplex was further assessed by MD simulations. The
docked 9CI - c-MYC Pu22 G-quadruplex complex was set
up using the xleapmodule in AMBER16molecular dynam-
ics package (http://ambermd.org/). The ligand parameter
was generated using the GAFF2 force field implemented in
the Antechamber program. The simulation was run using
parmbsc1 (65) version of Cornell et al. force field withOL15
modifications (66–68). Two potassium ions were placed at
the center of the G-tetrads. The complex was further neu-
tralized by adding K+ ions. The system was solvated using
Amber-adapted Joung and Chetham (69) parameters spe-
cific for TIP3P waters. The solvated box whose boundary
extended at least 10 A˚ from any solute atom was used as
the starting configuration for our simulation. The complex
was first minimized using 1000 steps of steepest descent, fol-
lowed by 1000 steps of conjugate gradient minimization.
A 300 ps MD equilibration was run in which the quadru-
plex was restrained, while the ions and water were allowed
to equilibrate. The system was gently heated from 0 to 300
K with a time step of 0.5 ps followed by another round at
constant pressure at 300 K for 1 ns. The constraints were
gradually relaxed until no constraints were applied on the
systems. The final production MD run was carried out for
1000 ns using ACEMD (70) molecular dynamics engine.
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Figure 2. (A) Cartoon representation of superimposed c-MYC Pu22 G-quadruplex structures in apo state (brown, model 1 in the NMR structure, PDB
1xav) and with quindoline (purple, model 1 in the NMR structure, PDB 2l7v). The two quindoline molecules are shown in cyan. (B) Superimposed
structures without ligands. (C) Connolly surface of c-MYC Pu22 G-quadruplex structure from PDB 2l7v. The red spheres highlight the central platform
on top of 3′ end G-quartet and at the bottom of 5′ end G-quartet, while green, yellow and blue spheres represent the locations of grooves connecting to
the central platform, respectively.
Figure 3. (A) Fluorescence emission spectra of 0.5 M 9CI in the presence of various oligonucleotides (0.5 M), ex = 405 nm. Fluorescence emission of
compound 9CI alone is shown in black. 0.5 M oligonucleotide samples were in 10 mMK2HPO4/KH2PO4 buffer solution with 100 mMKCl at pH 7.0.
(B) Fluorescence intensity enhancement of 0.5 M 9CI against concentration of different DNA oligonucleotides. (C) Fluorescence intensity of 9Cl in the
presence of c-MYC Pu18, c-MYC Pu22, c-MYC Pu24 and c-MYC Pu27. Both 9Cl and DNA are 0.5 M. ex = 405 nm, em = 472 nm.
Figure 4. Electrophoresis of DNA oligonucleotides on 20% non-
denaturing acrylamide gel. (A) Gel stained by SYBR Gold after elec-
trophoresis; (B) DNA samples were premixed with 20 M 9CI before
the electrophoresis. SYBR Gold used for staining was diluted ten thou-
sand times from original stocking solution with TBE (Tris-borate-EDTA)
buffer. 80 pmol DNAs were loaded into the different wells except for c-
MYC Pu22 (160 pmol) in lane 3. Lane 1: DNAmarker with 22 nucleotides;
lane 2: c-MYC Pu22 (80 pmol); lane 3: c-MYC Pu22 (160 pmol); lane 4:
TTA; lane 5: c-KIT1; lane 6: c-KIT2; lane 7: VEGF; lane 8: TBA; lane 9:
CT4; lane 10: 19AT.
cut-off, and 0.0001 A˚ tolerance was allowed for the SHAKE
algorithm, an integration step of 2 fs, constant pressure of 1
ATMat 300K temperature. The frameswere collected every
20 ps and the analysis of the trajectory was performed us-
ing the CPPTRAJ (71) module of AMBER. VMD (72) was
used to visualize the trajectories, and the figures were made
in the ICM-Pro software (www.molsoft.com) and PyMOL
(www.pymol.org).
RESULTS
Structure-based virtual screening for identifying fluorescent
probes
In the quindoline–c-MYC Pu22 G-quadrupelx complex
structure (PDB code 2l7v), both 3′ and 5′ flanking se-
quences exhibit ligand-induced reorientation in the bind-
ing pockets. Pockets in the complex structure and in apo
state (Figure 2) were used as potential binding sites. Con-
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Figure 5. Visualization of 9CI mixed with DNA oligonucleotides under UV light. (A) 5 M 9CI and 5 MDNA samples in 10 mM KH2PO4/K2HPO4
buffer with 100 mMKCl at pH 7.0. (B) Lane 1: 200 M c-MYC Pu22 DNA; lane 2: 50 M 9CI; lane 3: 25 M c-MYC Pu22 DNA + 25 M 9CI; lane 4:
50 M c-MYC Pu22 DNA + 50 M 9CI; lane 5: 100 M c-MYC Pu22 DNA + 100 M 9CI; lane 6: 200 M c-MYC Pu22 DNA + 200 M 9CI.
and Autodock 4.0 (63) was carried out to screen for flu-
orescent probes. Compounds with fluorophores from the
Chinese National Compound Library of Peking Univer-
sity (PKU-CNCL) were clustered through structural sim-
ilarity analysis using Open Babel (64). The representative
compounds were selected for virtual screening. The bind-
ing modes of the representative compounds in the clefts
were first predicted by AutoDock Vina, which achieves
an approximately two orders of magnitude speed-up com-
pared with AutoDock 4.0. Compounds with docking scores
ranked in the top 30% from Autodock Vina were selected
and re-docked using Autodock 4.0 to predict their binding
poses with greater accuracy. Binding poses with a cluster
population size>10 (out of 100) were visually inspected for
their fitness within the binding pockets. Twenty representa-
tive compounds were purchased and tested for their fluores-
cence response to DNA oligonucleotides that adopt differ-
ent secondary structures.
Fluorescence intensity measurement in solution and structure
optimization
Eighteen DNA oligonucleotides (Supplementary Table S1)
with the potential to form single strand, duplex, triplex, and
G-quadruplexes were employed to check the fluorescence
response of the selected compounds. Compound 1 and 2
exhibited enhanced fluorescence intensity at different ex-
citing and emitting wavelengths (Figure 1, Supplementary
Figure S3 and Table S2). In view of the selectivity of com-
pound 2 for c-MYC Pu22 G-quadruplex, it was chosen as
the template to further search for compounds with higher
selectivity from the database. New ligands with groups com-
mon in compound 2 or with bioisosteres to them were pur-
chased and synthesized (Figure 1, Supplementary Figure
S1, Schemes S1 and Figures S4 and S5), and their fluores-
cence response to the eighteen oligonucleotides was mea-
sured (Figure 1 and Supplementary Figure S1).
In vitro fluorescence selectivity of 9CI
9CI (compound 5), with anthracene ring replacing 4-
ethenyl-N,N-dimethylaniline in compound 2, exhibited high
fluorescence response and selectivity against c-MYC Pu
22 G-quadruplex (Figure 3). The absorbance spectrum of
9CI displayed two vibronic bands centered at 263 and 405
nm (Supplementary Figure S6A). To avoid overlap with
the nucleic acid absorbance, the fluorescence spectra were
scanned with the excitation wavelength at 405 nm. Com-
pound 9CI alone in buffer displayed extremely negligible
emission at 472 nm. With gradual titration of c-MYC Pu22
G-quadruplex DNA (up to 2 M), the fluorescence emis-
sion intensity at 472 and 503 nm exhibited a dramatic in-
crease (Figure 3B), even without a distinct shift in ab-
sorption (Supplementary Figure S6B). In contrast, non-
significant fluorescence enhancements were observed when
9CI was mixed or titrated with other DNA sequences, in-
cluding antiparallel G-quadruplex (Bom17, Asc20, CT4,
TBA, 21CTA), parallel G-quadruplex (c-KIT 1, c-KIT 2,
Kras, VEGF, AKT1), mixed G-quadruplex (TTA, TTA
45, Plas24), trinucleotide (CGG12), duplex (19AT), single
strand and triplex (Figure 1, Supplementary Table S1, Fig-
ure 3). 9CI did not yield significant fluorescent response to-
wards the wild-type c-MYC G-quadruplex forming DNA
oligonucleotides (Pu18, Pu24 and Pu27) (Supplementary
Table S1, Figure 3C). Selectivity was further visualized
by staining different DNA oligonucleotides with 9CI and
SYBR Gold on a native gel (Figure 4). 0.5 and 1 equiv. of
9CI selectively stained c-MYC Pu22 G-quadruplex forming
oligonucleotide and exhibited concentration dependence
(lanes 2–3 in Figure 4). Meanwhile, the fluorescence inten-
sity response of 9CI with c-MYC Pu22 G-quadruplex in so-
lution could be observed by visualization under UV light
radiation (Figure 5). The detection limit assay showed that
3 nM c-MYC Pu22 G-quadruplex forming DNA oligonu-
cleotide was able to activate fluorescence emission of 9CI
(Supplementary Figure S7). With the fluorescence response
of quinine sulfate as the standard, the fluorescence quan-
tum yields of 9Cl in the free and c-MYC Pu22-bound state
were calculated as 0.017 and 0.221, respectively. The fluo-
rescence quantum yield of 9Cl increased around 13 folds
after the addition of c-MYC Pu22 DNA. No obvious flu-
orescence enhancement was observed for 9Cl with eight
RNAG-quadruplex forming oligonucleotides (Supplemen-
tary Table S1, Figure S2).
Selective recognition of 9CI with c-MYCPu22G-quadruplex
ex vivo
Co-localization of c-MYC Pu22 G-quadruplex and 9CI is
an intuitive way to determine whether 9CI is able to rec-
ognize c-MYC Pu22 G-quadruplex in live cells. Negligi-
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Figure 6. Fluorescence images of A549 cells transfected with 40 pmol c-
MYC Pu22 DNA G-quadruplex forming oligonucleotide labelled with 5′-
Cy5 using lipofectamine 2000 and then incubated with 5 M 9Cl for 2
hours successively. (A) Fluorescence signal collected between 655–755 nm
at ex = 635 nm, (B) fluorescence signal collected between 425–470 nm at
ex = 405 nm, (C) fluorescence signal collected between 500 and 545 nm
at ex = 405 nm, (D) merged image of (A) and (C), (E) merged images of
(A), (B), (C) and the bright field. Scale bar, 20 m.
bation with cells (Supplementary Figure S8), and the G4-
activated fluorescence of 9CI was barely influenced by the
presence of cell lysates (Supplementary Figure S9). This
implies its reliability and biocompatibility for bio-imaging
in cells. Confocal laser scanning microscopy was employed
to check their distribution in cells. 40 pmol c-MYC Pu22
DNA G-quadruplex-forming oligonucleotide labelled with
5′-Cy5 was transfected into A549 cells by using lipofec-
tamine 2000. Negligible cell death was observed after 5 h in-
cubation at 37◦C, and the cells were further incubated with
5 M 9CI for 2 h. Upon excitation of Cy5 at 635 nm, red
fluorescence signals emitted from the cells explored the dis-
tribution of c-MYC Pu22 G-quadruplex in the cells (Fig-
ure 6A). Interaction with c-MYC Pu22 G-quadruplex en-
ables 9CI to emit strong blue and green fluorescence sig-
nals in the cells at 405 nm (Figure 6B and C). Notably,
most blue and green fluorescence signals (9CI) were co-
localized with red fluorescence signals from the labelled c-
MYC Pu22 G-quadruplex with Pearson correlation coeffi-
cient (PCC) 0.90, which indicated recognition between 9CI
and c-MYC Pu22 G-quadruplex (Figure 6D). However, af-
ter 40 pmol labelled TTA (telomeric DNA sequence) or c-
KIT1 G-quadruplex DNA was transfected into A549 cells
with the addition of 9CI, almost no co-localization was ob-
served between the TTA or c-KIT1 G-quadruplex struc-
tures and 9CI (Supplementary Figure S10 and S11). The
recognition between 9CI and c-MYC Pu22 G-quadruplex
was further proved by FRET (Fo¨rster resonance energy
transfer) between 9CI and the Cy3 labelled c-MYC Pu22
G-quadruplex forming oligonucleotide in the cells (Supple-
mentary Figure S12).
Bio-imaging for the functional aptamer in live cells
Compound 9CI displayed highly selective fluorescent recog-
nition for c-MYC Pu22 G-quadruplex in vitro and in live
cells. This encouraged us to exploit the 9CI - c-MYC Pu22
G-quadruplex complex as the fluorescent response core in a
DNAmimic of fluorescent proteins to locate bio-functional
molecules in cells, such as aptamers, and biomarkers. Ap-
tamers are single-stranded DNA or RNA oligonucleotides
with unique molecular recognition and binding capabili-
ties specific to various targets, including small molecules,
proteins, and live cells (73–75). The identification of their
targeted cells and targets in live cell benefits the mecha-
nism exploration and further optimization. Aptamer SL1
was found to affect the phosphorylation level in A549 and
suppress cancer cell motility (76). To locate aptamer SL1 in
cells, a fluorescent probe (c-MYC Pu22-MFP; Table 1) was
constructed with two segments: a reporter strand bearing
two repeated c-MYC Pu22 G-quadruplex sequences bind-
ing with 9CI and a matched recognition strand with the
extended aptamer SL1-M (Table 1). The constructed fluo-
rescent probe (c-MYC Pu22-MFP and 9CI) showed high
fluorescent recognition for the extended SL1 (SL1-M) in
vitro through hybridization (Supplementary Figure S13). At
first, SL1-M was incubated with A549 cells in DPBS for 30
min at room temperature, following which c-MYC Pu22-
MFP and 9CI were incubated to the cells sequentially (Fig-
ure 7). After the cells were washed with buffer three times,
the bright blue ring and the green ring on the cellular pe-
riphery of A549 cells at 405 nm excitation suggested the ap-
tamer SL1 might target the membrane receptors of A549
cells (Figure 8), whereas only weak fluorescence was ob-
served in the control HepG2 cells. This is consistent with the
reportedmechanism that SL1might target c-Met, a cell sur-
face receptor for the hepatocyte growth factor in A549 cells
(76). However, no signal was observed for SL1-M in con-
trol experiment carried out with a fluorescent probe (TTA2-
MFP in Table 1) constructed with the TTA G-quadruplex
forming oligonucleotide sequence replacing c-MYC Pu22
G-quadruplex forming oligonucleotide sequence (Figure 8).
In order to highlight the application of locating aptamers
in live cell, additional DNA oligonucleotides, based on
AS1411, were constructed (Supplementary Table S3).Using
the same protocol, a blue ring and a green ringwas observed
on the cellular periphery of A549 cells at 405 nm excitation
(Supplementary Figure S14), suggesting aptamer AS1411
might target protein at the cell surface. This is consistent
with the report that aptamer AS1411 could bind with nu-
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Figure 7. Schematic illustration of locating aptamers in cells by DNA mimic of fluorescent proteins with the 9CI–c-MYC Pu22 G-quadruplex complex as
the fluorescent response core.










Compound 9CI exhibited high selectivity for c-MYC Pu22
G-quadruplex in in vitro and ex vivo and the constructed
probe succeeded in locating aptamer SL1 at the periphery of
A549 cells. These implied its potential on improving the pre-
cision of nucleic acid mimics of fluorescent proteins to track
biomolecules in cells. Dissection of the recognition mecha-
nism would provide important clues for designing ligands
or fluorescent probes for a specific G-quadruplex structure.
Job plot analysis showed that 9CI bound with c-MYC Pu22
G-quadruplex with 1:1 stoichiometry (Supplementary Fig-
ure S15). ITC (Isothermal titration calorimetry) assay and
fluorimetric titration showed that the dissociation constants
were on the order of magnitude of 10−5 M−1 (Supplemen-
tary Figures S16 and S17), suggesting a relative weak inter-
action between 9CI and c-MYC Pu22 DNAG-quadruplex.
CD (Circular Dichroism) spectra showed that the addition
of 9CI did not change the topology of the c-MYC Pu22
DNA G-quadruplex and other DNA structures (Supple-
mentary Figure S18).
Fluorescence alterations upon recognition between 9CI
and the mutant c-MYC Pu22 G-quadruplex sequences (Ta-
ble 2) were analyzed to investigate the binding site of 9CI.
The oligonucleotides mutated at the 5′ end loop (G2 > C2,
A3 > T3), 3′ end loop (T20 > A20, A22 > T22), middle
loop (T11 > A11), and 3′ end G-quartet (G10 > T10) were
purchased fromSangon (Shanghai, China). TheCD spectra
showed that these mutated DNA oligonucleotides adopted
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Figure 8. Confocal microscope images of the treated A549 cells and
HepG2 cells at 405 nm excitation. A549 cells was incubated with SL1-M
for 30 min at room temperature, and washed by 1 ml DPBS twice. Then,
the cells were incubated with 500 nM MFP (c-MYC Pu22-MFP/ TTA-
MFP) and 5 M 9CI for 10 min. Fluorescence was collected after the cells
were washed with DPBS three times again. (A) Fluorescence collected at
425–470 nm emission channel, (B) fluorescence collected at 500–545 nm
emission channel, (C) merged image of (A) and (B) and bright field. Scale
bar, 10 m.
Figure 9. Fluorescence emission spectra of 0.5 M 9CI with the addition
of 0.5 M c-MYC Pu22 DNAG-quadruplex oligonucleotide and the mu-
tant oligonucleotides, ex = 405 nm. Fluorescence emission of 9CI alone
is shown in black, and 0.5 M oligonucleotides were prepared in 10 mM
K2HPO4/KH2PO4, 100 mM KCl, pH 7.0.
and the addition of 9CI did not change their topology (Sup-
plementary Figure S19). Upon the titration of 9CI, oligonu-
cleotides with mutation at 5′ end (G2 > C2, A3 > T3) and
the loop (T11 > A11) exhibited the same level of fluores-
cence response as the native oligonucleotide, suggesting that
the binding site might be away from the 5′ end G-quartet
and T11 loop (Figure 9). Surprisingly, the mutation of T
for G10 in the 3′ end G-quartet did not change the G-
quadruplex structure (Supplementary Figure S19). Instead,
the weak fluorescence response (Figure 9) indicated that the
mutation onG10might prevent the interaction between 9CI
and 3′ end G-quartet. The mutation from T20 to A20 re-
sulted in negligible fluorescence response, and the oligonu-
cleotide with mutation A22 > T22 exhibited the highest
fluorescence enhancement to 9CI. Non-significant fluores-
cence change with mutation in the 5′ end loop and signifi-
cant fluorescence variation with the mutation in the 3′ end
G-quartet and the T20-A22 loop indicated that compound
9CI might be located between the T20-A22 loop and 3′ end
G-quartet.
Recognition mechanism explored by automated docking and
molecular dynamics simulations.
Fluorescence changes of 9CI with the mutant c-MYC Pu22
G-quadruplex oligonucleotides showed 3′ end cleft could
be the recognition site. Exploring their recognition mode at
the atomic level could provide detailed information for fur-
ther structural modification. Automated docking coupled
with molecular dynamics simulations were carried out to
explore its recognition mechanism in the 3′ end cleft. 9CI
was docked into the cleft at the 3′ end of c-MYC Pu22 G4-
quadruplex structure (PDB ID: 2l7v) with 200 repeat runs
using Autodock 4.0. The predicted binding conformation
with the highest frequency of occurrence among 200 con-
formations was considered as the initial recognition mode.
In this orientation (Supplementary Figure S20), the an-
thracene ring was found to stack on the top of G10 and
G15 in 3′ end G-quartet surface; three nitrogen atoms in
the triazine ring and nitrogen atoms N1 or N2 (Scheme 1)
interacted with the phosphate oxygen atoms of T11 via elec-
trostatic interaction and the phenyl ring stacked with the
thymine of T11. In this case, the initial interaction between
9CI and the G-quadruplex structure constituted the basis
for the dynamic recognition model.
One sec molecular dynamics simulation (Supplemen-
tary Figure S21) was carried out to check the dynamic
recognition between 9CI and c-MYC Pu22 G-quadruplex.
In the initial contact, the triazine ring was attracted to
the phosphate oxygen atoms through electrostatic interac-
tion, while the anthracene ring of 9CI stacked on two gua-
nines of the 3′ terminal end G-quartet (Figure 10A). As the
anthracene ring approached the T20-A21-A22 loop, A22
moved away from the approaching ligand (Figure 10B).
Further insertion of 9CI disrupted T20–A22 base pair, and
forced the bases in loop T20–A21–A22 to stack (Figure
10C). In the following structural perturbations, 9CI and
the T20–A21–A22 loop translated and rotated to obtain
an optimal stacking mode. Finally, T20–A22 base pair re-
formed and the anthracene ring was sandwiched between
T20–A22 base pair and G15–G19 on the 3′ end G-quartet
(Figure 10F, Supplementary Figure S22). The triazine and
the phenyl ring stacked on top of G6 (Figure 10F), while
the bridge nitrogen atom interactedwith the phosphate oxy-
gen atom in T7 via electrostatic interaction (Supplemen-
tary Figure S22C). These stable interactions prevented in-
tramolecularmotions of 9CI, and ensured the dominance of
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Figure 10. Dynamic recognition between 9CI and c-MYC Pu22 G-quadruplex explored by molecular dynamic simulations.
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confirmed by the remarkable fluorescence enhancement of
9Cl in the glycerol at different concentrations (Supplemen-
tary Figure S23).
DISCUSSION
Selectivity for the cleft at the 3′ end
As a functional structural unit, G-quadruplex structures
have been assumed to be anti-tumour or anti-viral targets
(79,80). However, the design of ligands selectively target-
ing a specific G-quadruplex structure in cells still remains a
challenge. Surprisingly, G-quadruplex structure was found
to be a key component for the fluorescent response of exoge-
nous fluorophores (HBI analogues) in some RNA/DNA
mimics of fluorescent proteins. Due to the lack of selec-
tivity for G-quadruplex structures in the mimics of FPs,
the addition of the exogenous HBI analogues would re-
sult in enormous fluorescence noise by encountering hun-
dreds of G-quadruplex in the genome. The noise can be re-
duced by identifying self-illuminating nucleic acid aptamers
that generate endogenous fluorophores or an alternative ap-
proach is to discover probes that selectively recognize the
specific G-quadruplex topology in the aptamer. However,
majority of G-quadruplex ligands described thus far show
little selectivity among different G-quadruplex structures.
9CI displays high selectivity for c-MYCPu22G-quadruplex
structure over other G-quadruplex topologies. No obvi-
ous fluorescence enhancement with three wide-type c-MYC
G-quadruplex forming DNA oligonucleotides (Pu18, Pu24
and Pu27) (Figure 3C) further suggested the potential of
9CI and c-MYC Pu22 G-quadruplex complex as the flu-
orescence response core on precisely locating target bio-
logical molecules in cells. CD spectra showed that addi-
tion of 9CI did not change the topologies of c-MYC Pu22
DNAG-quadruplex (Supplementary Figure S18). Fluores-
cence variance upon the recognition between 9CI and c-
MYC Pu22 G-quadruplex forming sequences mutated in
the loops at 3′ end, 5′ end or in the middle suggested that
compound 9CI bound close to the T20-A22 loop and at the
3′-end G-quartet instead of 5′ end. The preference for only
one terminal end G-quartet was further supported by Job
plot analysis, which showed a 1:1 stoichiometry between
9CI and c-MYC Pu22 G-quadruplex.
Induced fit recognition mechanism supported by the relation-
ship between the fluorescence response and the structures of
9CI analogues
Generally, the fluorescence response of G-quadruplex
probes arises from the  stacking stabilization with G-
quartet (32,81). The optimization of analogues was derived
from the chemical skeleton of compound 2. Twenty three
compounds with similar chemical groups in compound 2
or with bioisostere to them were measured for their fluo-
rescence response to eighteen DNA oligonucleotides. The
complicated relationship between these structures and their
fluorescence response to c-MYC Pu22 G-quadruplex could
not be explained by any single stacking state. However,
some structure-fluorescence relationship could be rational-
ized.
(1) Except for c-MYC Pu22 G-quadruplex, 9CI does not
exhibit obvious fluorescence to other G-quadruplex
structures (Figure 1). This suggests that stacking with
the common G-quartet is not determinant for the fluo-
rescence of 9CI.
(2) Naphthalimides and benzoheterocycles groups stack
well with the G-quartet (82,83). With these two frag-
ments replacing the triazine ring and N-phenyl rings in
compound 5 (9CI), compounds 8 and 9were purchased
and measured for their fluorescence response to differ-
ent nucleic acid structures (Figure 1). Their negligible
fluorescence response implies that the stacking between
the anthracene ring in 9CI and the G-quartet is not cru-
cial for the strong fluorescence response.
(3) The anthracene ring in 9CI is assumed to be the fluo-
rophore. Compounds 3–6 with different fluorophores
were measured for their fluorescence response. Com-
paredwith 9CI, compounds 3 and 4with small aromatic
rings did not display obvious fluorescent signals with or
without DNA oligonucleotides. This implies that fluo-
rophores with big stacking surface are helpful. With the
same structural components, compound 5 (9CI) and
compound 6 with substitutions at different positions
of the anthracene ring possess conjugated system at
the similar size. However, completely different fluores-
cence response with c-MYC Pu22 G-quadruplex sug-
gests that only big stacking surface with the G-quartet
is not enough for the strong fluorescent response.
(4) In spite of sharing >70% similarity with 9CI, com-
pound 7 did not display fluorescence. This suggests that
the N-phenyl ring in 9CI is important in the recognition
process and cannot be replaced by the piperidine ring in
compound 7.
(5) Compounds 10–25 (Supplementary Figure S1) with
random replacement for the N-phenyl, the triazine ring
and the anthracene ring (parts A–D in Scheme 1) did
not show obvious fluorescence response, suggesting
that the cooperation of the rings play roles in the strong
fluorescence response of 9CI.
Molecular dynamics simulations demonstrated that the
recognition between 9CI and c-MYC G-quadruplex con-
sisted of the kinetic match, dynamic recognition and the
final stacking. The harmonious cooperation between the
structural rearrangement of 3′ end loop and the systematic
translocation of 9CI was critical for the induced fit (Fig-
ure 11).WhenN-phenyl is replaced by piperidine ring (com-
pound 7), significant reduction in fluorescence could be due
to the absence of the stacking betweenN-phenyl and T11 in
the initial recognition. Weak fluorescence response of com-
pounds 8 and 9 suggests the triazine ring andN-phenyl rings
in 9CI play an important role in the initial fitting and the dy-
namic recognition before 9CI reaches the final stacked state.
If compound 6 were able to reach the same final stacked
state as 9CI, the anthracene ring could enable compound 6
to be a light-up fluorescent probe for G-quadruplex. How-
ever, insignificant fluorescence enhancement was observed
for compound 6, suggesting that the relative orientation
among the anthracene ring, the triazine ring and the phenyl
rings might interfere with the initial contact and prevent








ollege London user on 28 February 2019
Nucleic Acids Research, 2019 13
cence response of 9CI for c-MYC Pu22 G-quadruplex over
other G-quadruplexes highlights the importance of A20–
T22 loop in the dynamic recognition and the sandwich in-
teraction. The fluorescence intensity variance with different
bioisoterisms of 9CI reflects the roles of different structural
components play in the recognition process.
CONCLUSION
As functional molecular structures, G-quadruplexes have
attracted wide attention from different areas. However, it
has been challenging to find a ligand or a fluorescent
probe targeting a specific G-quadruplex structure. In this
study, we identified compound 9CI exhibiting selective and
strong light-up fluorescence response to c-MYC Pu22 G-
quadruplex over other G-quadruplex structures. 9CI ex-
hibited good biocompatibility without inhibition in some
tumor cells (9CI at 20 M), fungi (9CI at 50 ppm), and
insects (9CI at 1000 ppm). The fluorescent probe con-
structed with 9CI and c-MYC Pu22 G-quadruplex form-
ing oligonucleotides as the fluorescent response unit suc-
ceeded in locating functional aptamer SL1 on the cellu-
lar periphery of A549 cells. Experimental and computa-
tional analysis demonstrated that: (a) the initial conforma-
tion match led to the structural interaction; (b) the high
selectivity came from the dynamic rearrangement and (c)
the thermodynamic stability of the complex determined the
strong fluorescence response. This was further supported by
the structure-fluorescence intensity relationship of the 9CI
analogues. This work demonstrates that: (i) it is possible to
discover fluorescence probes or ligands to recognize a spe-
cific G-quadruplex structure; (ii) besides the single recog-
nition state, the dynamic recognition process could provide
clues for designing fluorescent probes or ligands with high
selectivity for a specific G-quadruplex structure; (iii) com-
plex consisting of a specific G-quadruplex and its unique
light-up fluorescent probe could work as the fluorescent re-
sponse core to improve their precision on biomedical imag-
ing and clinical diagnosis.
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